These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23962079)

  • 1. Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.
    Mingorance-Le Meur A; Ghisdal P; Mullier B; De Ron P; Downey P; Van Der Perren C; Declercq V; Cornelis S; Famelart M; Van Asperen J; Jnoff E; Courade JP
    Br J Pharmacol; 2013 Nov; 170(5):1053-63. PubMed ID: 23962079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALX 1393 inhibits spontaneous network activity by inducing glycinergic tonic currents in the spinal ventral horn.
    Eckle VS; Antkowiak B
    Neuroscience; 2013 Dec; 253():165-71. PubMed ID: 23994185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.
    Mostyn SN; Carland JE; Shimmon S; Ryan RM; Rawling T; Vandenberg RJ
    ACS Chem Neurosci; 2017 Sep; 8(9):1949-1959. PubMed ID: 28574249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine transporter type 2 (GlyT2) inhibitor ameliorates bladder overactivity and nociceptive behavior in rats.
    Yoshikawa S; Oguchi T; Funahashi Y; de Groat WC; Yoshimura N
    Eur Urol; 2012 Oct; 62(4):704-12. PubMed ID: 22341128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.
    Winters BL; Rawling T; Vandenberg RJ; Christie MJ; Bhola RF; Imlach WL
    Br J Pharmacol; 2018 Jun; 175(12):2337-2347. PubMed ID: 29500820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
    Takahashi Y; Hara K; Haranishi Y; Terada T; Obara G; Sata T
    Pharmacol Biochem Behav; 2015 Mar; 130():46-52. PubMed ID: 25579325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
    Imam MZ; Kuo A; Nicholson JR; Corradini L; Smith MT
    Pharmacol Rep; 2020 Oct; 72(5):1418-1425. PubMed ID: 32715433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain.
    Hermanns H; Muth-Selbach U; Williams R; Krug S; Lipfert P; Werdehausen R; Braun S; Bauer I
    Neurosci Lett; 2008 Nov; 445(3):214-9. PubMed ID: 18793697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain.
    Mostyn SN; Rawling T; Mohammadi S; Shimmon S; Frangos ZJ; Sarker S; Yousuf A; Vetter I; Ryan RM; Christie MJ; Vandenberg RJ
    J Med Chem; 2019 Mar; 62(5):2466-2484. PubMed ID: 30714733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relief of cancer pain by glycine transporter inhibitors.
    Motoyama N; Morita K; Shiraishi S; Kitayama T; Kanematsu T; Uezono Y; Dohi T
    Anesth Analg; 2014 Oct; 119(4):988-995. PubMed ID: 25076101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain.
    Omori Y; Nakajima M; Nishimura K; Takahashi E; Arai T; Akahira M; Suzuki T; Kainoh M
    J Pharmacol Sci; 2015 Mar; 127(3):377-81. PubMed ID: 25837937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain.
    Nishikawa Y; Sasaki A; Kuraishi Y
    J Pharmacol Sci; 2010; 112(3):352-60. PubMed ID: 20173309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.
    Carland JE; Handford CA; Ryan RM; Vandenberg RJ
    Neurochem Int; 2014 Jul; 73():211-6. PubMed ID: 24036283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleoyl-L-carnitine inhibits glycine transport by GlyT2.
    Carland JE; Mansfield RE; Ryan RM; Vandenberg RJ
    Br J Pharmacol; 2013 Feb; 168(4):891-902. PubMed ID: 22978602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine transport inhibitors for the treatment of pain.
    Vandenberg RJ; Ryan RM; Carland JE; Imlach WL; Christie MJ
    Trends Pharmacol Sci; 2014 Aug; 35(8):423-30. PubMed ID: 24962068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
    Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
    Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
    Rousseau F; Aubrey KR; Supplisson S
    J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model.
    Haranishi Y; Hara K; Terada T; Nakamura S; Sata T
    Anesth Analg; 2010 Feb; 110(2):615-21. PubMed ID: 20081141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543.
    Benito-Muñoz C; Perona A; Felipe R; Pérez-Siles G; Núñez E; Aragón C; López-Corcuera B
    ACS Chem Neurosci; 2021 Jun; 12(11):1860-1872. PubMed ID: 34003005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.